Cargando…
TGF-β1-Induced Epithelial–Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells
Breast cancer progression toward metastatic disease is linked to re-activation of epithelial–mesenchymal transition (EMT), a latent developmental process. Breast cancer cells undergoing EMT lose epithelial characteristics and gain the capacity to invade the surrounding tissue and migrate away from t...
Autores principales: | Johansson, Joel, Tabor, Vedrana, Wikell, Anna, Jalkanen, Sirpa, Fuxe, Jonas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306317/ https://www.ncbi.nlm.nih.gov/pubmed/25674539 http://dx.doi.org/10.3389/fonc.2015.00003 |
Ejemplares similares
-
MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer
por: Johansson, J, et al.
Publicado: (2013) -
Magnolol Suppresses TGF-β-Induced Epithelial-to-Mesenchymal Transition in Human Colorectal Cancer Cells
por: Chei, Sungwoo, et al.
Publicado: (2019) -
Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue
por: Tellez-Gabriel, Marta, et al.
Publicado: (2022) -
Calcium Channel Protein ORAI1 Mediates TGF-β Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells
por: Kang, Qingjie, et al.
Publicado: (2021) -
Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
por: Li, Xiaoxiao, et al.
Publicado: (2022)